Are there opportunities to improve care as patients transition through the cancer care continuum? A scoping reviewJaling Kersen, Stefan Kurbatfinski, Abigail Thomas, Seremi Ibadin, Areej Hezam, Diane Lorenzetti, Shamir Chandarana, Joseph C Dort, Khara M Sauro
12 December 2024
Socioeconomic inequality in cervical cancer screening uptake among women in sub-Saharan Africa: a decomposition analysis of Demographic and Health Survey dataYordanos Sisay Asgedom, Gizachew Ambaw Kassie, Aklilu Habte, Daniel Bekele Ketema, Fantu Mamo Aragaw
10 December 2024
Hepatic arterial infusion chemotherapy plus regorafenib compared with regorafenib alone as second-line therapy for advanced hepatocellular carcinoma: a randomised controlled trial protocolHe Zhao, Xiaowu Zhang, Pengfei Tian, Yingen Luo, Wei Sun, Ying Li, Jingui Li, Tao Gong, Zhengqiang Yang, Peng Song, Xiao Li
7 December 2024
Systematic review of prognostic models for predicting recurrence and survival in patients with treated oropharyngeal cancerJanine Dretzke, Ahmad K Abou-Foul, Esther Albon, Bethany Hillier, Katie Scandrett, Malcolm J Price, David J Moore, Hisham Mehanna, Paul Nankivell
5 December 2024
Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorderMiryam Yusufov, William F Pirl, Joseph A Greer, Emanuele Mazzola, Kristy L. Dalrymple, James A Tulsky, Ilana M Braun, R. Kathryn McHugh
5 December 2024
Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trialPeng-Fei Zhang, Wei-Han Zhang, Xi-Jiao Liu, Du He, Kun Yang, Hong-Feng Gou, Jian-Kun Hu
4 December 2024
Pembrolizumab (MK-3475) plus platinum and gemcitabine as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (PIPER): a phase 2, multicentre, single-arm protocol study in MalaysiaSok Ching Cheong, Bawani Selvam, Gwo Fuang Ho, Ibtisam Muhamad Nor, Chih Kiang Tan, Yoke Fui Wong, Soo Hwang Teo, Kue Peng Lim, Annie Wai Yeeng Chai, Abqariyah Yahya, Wan Zamaniah Wan Ishak
3 December 2024
Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signalsJean-Matthieu L'Orphelin, Angélique Da Silva, Jean Cabon, Joachim Alexandre, Charles Dolladille
3 December 2024
Australian Particle Therapy Clinical Quality Registry (ASPIRE) protocol (TROG 21.12): a multicentre prospective study on patients with rare tumours, treated with radiation therapyKelly Skelton, Peter Gorayski, Scott Penfold, Amber Murray, Daniel Hamilton, Adam Yeo, Sophie Jessop, Eunji Hwang, Joshua Dass, Hien Le
27 November 2024
A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UKHilary Glen, Amit Bahl, Louisa Fleure, Noel Clarke, Suneil Jain, Tania Kalsi, Vincent Khoo, Junaid Mobeen
27 November 2024
